A Long Term Effects of a New Onset Psychosis after DBS Treated with Quetiapine in a Patient with Parkinson's Disease

Deep Brain Stimulation represents a therapeutic option for PD patients. In this paper, we present and discuss a case of acute delirium and psychosis manifesting after DBS in a 58-years-old man affected by Parkinson's Disease. We highlight the importance of an exhaustive psychiatric evaluation i...

Full description

Bibliographic Details
Main Authors: Piccoli, Sara, Perini, Giulia, Pizzighello, Silvia, Vestri, Alec, Ferri, Giovanni, Toffanin, Tommaso, Follador, Halima, Martinuzzi, Andrea
Format: Online
Language:English
Published: Korean Neuropsychiatric Association 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310913/
id pubmed-4310913
recordtype oai_dc
spelling pubmed-43109132015-02-10 A Long Term Effects of a New Onset Psychosis after DBS Treated with Quetiapine in a Patient with Parkinson's Disease Piccoli, Sara Perini, Giulia Pizzighello, Silvia Vestri, Alec Ferri, Giovanni Toffanin, Tommaso Follador, Halima Martinuzzi, Andrea Case Report Deep Brain Stimulation represents a therapeutic option for PD patients. In this paper, we present and discuss a case of acute delirium and psychosis manifesting after DBS in a 58-years-old man affected by Parkinson's Disease. We highlight the importance of an exhaustive psychiatric evaluation in candidates for DBS and we underline the severity and non-reversibility of some adverse events associated with the implantation, suggesting the use of Quetiapine in the management of these effects. Acute psychosis may be listed as a potential severe adverse event associated with DBS, even in patients without a clear cut previous history of psychiatric disorders. Korean Neuropsychiatric Association 2015-01 2015-01-12 /pmc/articles/PMC4310913/ /pubmed/25670958 http://dx.doi.org/10.4306/pi.2015.12.1.146 Text en Copyright © 2015 Korean Neuropsychiatric Association http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Piccoli, Sara
Perini, Giulia
Pizzighello, Silvia
Vestri, Alec
Ferri, Giovanni
Toffanin, Tommaso
Follador, Halima
Martinuzzi, Andrea
spellingShingle Piccoli, Sara
Perini, Giulia
Pizzighello, Silvia
Vestri, Alec
Ferri, Giovanni
Toffanin, Tommaso
Follador, Halima
Martinuzzi, Andrea
A Long Term Effects of a New Onset Psychosis after DBS Treated with Quetiapine in a Patient with Parkinson's Disease
author_facet Piccoli, Sara
Perini, Giulia
Pizzighello, Silvia
Vestri, Alec
Ferri, Giovanni
Toffanin, Tommaso
Follador, Halima
Martinuzzi, Andrea
author_sort Piccoli, Sara
title A Long Term Effects of a New Onset Psychosis after DBS Treated with Quetiapine in a Patient with Parkinson's Disease
title_short A Long Term Effects of a New Onset Psychosis after DBS Treated with Quetiapine in a Patient with Parkinson's Disease
title_full A Long Term Effects of a New Onset Psychosis after DBS Treated with Quetiapine in a Patient with Parkinson's Disease
title_fullStr A Long Term Effects of a New Onset Psychosis after DBS Treated with Quetiapine in a Patient with Parkinson's Disease
title_full_unstemmed A Long Term Effects of a New Onset Psychosis after DBS Treated with Quetiapine in a Patient with Parkinson's Disease
title_sort long term effects of a new onset psychosis after dbs treated with quetiapine in a patient with parkinson's disease
description Deep Brain Stimulation represents a therapeutic option for PD patients. In this paper, we present and discuss a case of acute delirium and psychosis manifesting after DBS in a 58-years-old man affected by Parkinson's Disease. We highlight the importance of an exhaustive psychiatric evaluation in candidates for DBS and we underline the severity and non-reversibility of some adverse events associated with the implantation, suggesting the use of Quetiapine in the management of these effects. Acute psychosis may be listed as a potential severe adverse event associated with DBS, even in patients without a clear cut previous history of psychiatric disorders.
publisher Korean Neuropsychiatric Association
publishDate 2015
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310913/
_version_ 1613182232201003008